Cargando…

565. Tocilizumab Use in COVID-19: Act(emra) to Inhibit Intubation and Decompensation

BACKGROUND: Tocilizumab is an IL-6 receptor inhibitor that has been utilized for the prevention and treatment of the cytokine storm inflammatory reaction in COVID-19. The objectives of this analysis were to evaluate clinical outcomes of tocilizumab treatment in relation to respiratory status improve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Willner, Debra M, Bengualid, Victoria, Zada, Ilanit, Berger, Judith, Patel, Nigam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776800/ http://dx.doi.org/10.1093/ofid/ofaa439.759

Ejemplares similares

56. Ertapenem Utilization: “CRE”ating Solutions for Improving Hospital Stay and Stewardship
por: Willner, Debra M, et al.
Publicado: (2020)

369. Clinical Characteristics of the First 177 Patients Admitted with COVID-19 at a Bronx Community Hospital
por: Bengualid, Victoria, et al.
Publicado: (2020)

525. Characteristics of HIV SARS-COV-2 Coinfection in a Highly HIV Seropositive Population in New York City
por: Willner, Debra M, et al.
Publicado: (2020)

62. Association Between Influenza Co-infection and Poor Outcomes in Patients Hospitalized with COVID-19
por: Bobadilla, Renato G, et al.
Publicado: (2020)

565 Sensitization Profile in Severe Asthma
por: Bozek, Andrzej, et al.
Publicado: (2012)

PT565. Prenatal nicotine exposure impairs adolescent mouse hippocampal function
por: TANASE, Shota, et al.
Publicado: (2016)

565. Implementing HIV Rapid Entry in a Community Infectious Disease Practice
por: Cafardi, John, et al.
Publicado: (2018)

565 Timing of COVID-19 during pregnancy and impact on placental pathology
por: Glynn, Shannon M., et al.
Publicado: (2021)

553. Critically Ill patients Receiving Tocilizumab Compared With Those Not Receiving Tocilizumab for Treatment of COVID-19
por: Leonard, Michael, et al.
Publicado: (2020)

565. Implementation of a Staphylococcus aureus Screening and Decolonization Program in a Multisite Urban Healthcare System
por: King-Morrieson, Tamara, et al.
Publicado: (2019)

563. Tocilizumab in the Treatment of Critical COVID-19 Pneumonia
por: Fisher, Matthew, et al.
Publicado: (2020)

Human CD8+ CD57- T(EMRA) cells: Too young to be called "old"
por: Verma, Kriti, et al.
Publicado: (2017)

Etiologies of Extreme Leukocytosis
por: Viner, Esther, et al.
Publicado: (2023)

565. Pilot Study of Prolonged Post-Discontinuation Antibiotic Exposure (PDAE) to Ampicillin Among Low Birthweight Preterm Infants
por: Boutzoukas, Angelique E, et al.
Publicado: (2022)

566. Tocilizumab: A Friend or a Foe in COVID-19 Management?
por: Hernandez, Jarelys M, et al.
Publicado: (2020)

342. Secondary Infections following Tocilizumab for Treatment of COVID-19 Pneumonia
por: Warner, Adam, et al.
Publicado: (2021)

Abdominal Obesity-Related Disturbance of Insulin Sensitivity Is Associated with CD8(+) EMRA Cells in the Elderly
por: Boßlau, Tim K., et al.
Publicado: (2021)

Cytotoxic CD161(−)CD8(+) T(EMRA) cells contribute to the pathogenesis of systemic lupus erythematosus
por: Xiong, Hui, et al.
Publicado: (2023)

564. Tocilizumab Induces Rapid, Sustained Improvement of Inflammatory Markers in COVID-19
por: Colgrove, Robert, et al.
Publicado: (2020)

P565: REAL-WORLD DATA AS SUPPLEMENTARY CONTROLS FOR THE PROSPECTIVE RANDOMIZED HOVON-103 TRIAL IN INTENSIVELY TREATED ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS
por: Hermans, Sjoerd, et al.
Publicado: (2023)

362. A Modified Early Warning Score Predicts Decompensation in COVID-19 Patients
por: Cavalier, Joanna S, et al.
Publicado: (2020)

565. Antimicrobial susceptibility profiles of Acinetobacter species in blood: 10-year experience from a major United States reference laboratory
por: Bisono Garcia, Bismarck S, et al.
Publicado: (2023)

400. Secondary Infections in COVID-19 Patients Receiving Tocilizumab in a Community Hospital
por: Usiak, Shauna, et al.
Publicado: (2020)

304. Impact of Antibiotic Prophylaxis Prior to Treatment with Steroids and Tocilizumab in COVID-19 Patients
por: de Novales, Francisco Javier Membrillo, et al.
Publicado: (2021)

Altered Nutrient Uptake Causes Mitochondrial Dysfunction in Senescent CD8(+) EMRA T Cells During Type 2 Diabetes
por: Callender, Lauren A., et al.
Publicado: (2021)

POS-565 ARTERIOVENOUS FISTULA BY NEPHROLOGIST IN COVID ERA
por: Bhargava, V., et al.
Publicado: (2021)

565 Impact of Municipal Ordinances on Firework-Related Injuries
por: Mefford, Austin T, et al.
Publicado: (2022)

554. Early Clinical Outcomes with Tocilizumab for Covid-19: A Two-Center Retrospective Study
por: Smoke, Steven, et al.
Publicado: (2020)

562. Tocilizumab for the Treatment of Severe COVID-19: A Retrospective, Multi-Center, Case-Matched Series
por: Norman, Sarah, et al.
Publicado: (2020)

539. Impact of Corticosteroids when Combined with Tocilizumab or Remdesivir for the Treatment of Severe SARS-CoV-2
por: Rosati, Michael, et al.
Publicado: (2021)

341. Evaluation of Antimicrobial Use and Prescribing Patterns During the COVID-19 Pandemic in Patients Receiving Tocilizumab
por: Barsoum, Barbara, et al.
Publicado: (2021)

551. Remdesivir and Tocilizumab for the Treatment of Severe COVID-19 in a Community Hospital: A Retrospective Cohort Study
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

Toccata y fuga en re menor, BWV 565
por: Bach, Johann Sebastian, 1685-1750
Publicado: (1997)

Genome Sequence of Klebsiella pneumoniae Respiratory Isolate IA565
por: Johnson, Jeremiah G., et al.
Publicado: (2014)

550. Clinical impact of Tocilizumab therapy in SARS-CoV-2 respiratory infections in ICU and non-ICU patients
por: Vyas, Nikunj M, et al.
Publicado: (2020)

Human CD8(+) EMRA T cells display a senescence‐associated secretory phenotype regulated by p38 MAPK
por: Callender, Lauren A., et al.
Publicado: (2017)

CMV-independent increase in CD27−CD28+ CD8+ EMRA T cells is inversely related to mortality in octogenarians
por: Martin-Ruiz, Carmen, et al.
Publicado: (2020)

562. Tocilizumab Use in the Second Trimester Pregnant Patients with Severe Covid-19 Pneumonia and their Maternal and Fetal Outcomes: Two Case Reports
por: iqbal, Fatima, et al.
Publicado: (2021)

534. The Use of Tocilizumab and Remdesivir in SARS- CoV-2 Patients in El Paso Texas: A Longitudinal Comparative Observational Study
por: Almaghlouth, Nouf K, et al.
Publicado: (2021)

297. Infectious Complications Associated with Tocilizumab Use in Patients Infected with SARS-CoV-2 at a Mid-Atlantic Hospital Consortium
por: Kent, Kristen R, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2jvoasg5fmfopa2rmbb93c6a5f